Opko Health (OPK) Operating Leases (2019 - 2026)

Opko Health (OPK) has 8 years of Operating Leases data on file, last reported at $34.0 million in Q2 2026.

• Quarterly Operating Leases fell 28.02% year-over-year to $34.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.0 million (down 28.02% YoY) and the FY2025 annual result came in at $36.8 million, down 24.64% from the prior year.
• Operating Leases retreated to $34.0 million in Q2 2026, from $35.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $64.8 million in Q3 2024 to a low of $28.0 million in Q4 2022.
• A 5-year average of $45.3 million and a median of $44.5 million in 2022 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases jumped 93.61% — and 2025, when it sank 44.02%.
• Tracing OPK's Operating Leases over 5 years: stood at $28.0 million in 2022, then soared by 93.61% to $54.1 million in 2023, then declined by 9.77% to $48.8 million in 2024, then retreated by 24.64% to $36.8 million in 2025, then decreased by 7.7% to $34.0 million in 2026.
• The last three Operating Leases figures came in at $34.0 million (Q2 2026), $35.6 million (Q1 2026), and $36.8 million (Q4 2025), per Business Quant data.